Disruption of Interleukin-1 Signaling Improves the Quality of Wound Healing

被引:93
|
作者
Thomay, Alan A.
Daley, Jean M.
Sabo, Edmond [2 ]
Worth, Patrick J.
Shelton, Leslie J. [3 ,4 ]
Harty, Mark W.
Reichner, Jonathan S.
Albina, Jorge E. [1 ]
机构
[1] Rhode Isl Hosp, Div Surg Res, Dept Surg, Providence, RI 02903 USA
[2] Rhode Isl Hosp, Dept Pathol, Providence, RI 02903 USA
[3] Brown Univ, Alpert Med Sch, Div Engn, Providence, RI 02912 USA
[4] Brown Univ, Dept Phys, Div Engn, Providence, RI 02912 USA
来源
AMERICAN JOURNAL OF PATHOLOGY | 2009年 / 174卷 / 06期
基金
美国国家卫生研究院;
关键词
FIBROBLAST PROLIFERATION; MURINE; CELLS; KERATINOCYTES; INFLAMMATION; NEUTROPHILS; METABOLISM; MODULATION; MICE;
D O I
10.2353/ajpath.2009.080765
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In this study, we investigated the role of interleukin (IL)-1 signaling in wound heating. IL-1 receptor type I (IL-1R) knockout (KO) mice showed reduced fibrosis in both cutaneous and deep tissue wounds, which was accompanied by a reduction in inflammatory cellular infiltration in cutaneous but not in deep tissue wounds. There were no differences in either total collagenolytic activity or in the expression of selected matrix metalloproteinases; or tissue inhibitors of metalloproteinases between the wound fluids from wildtype or IL-1R KO mice. However, wound fluids from IL-1R KO mice contained lower levels of IL-6 compared with wild-type controls. In addition, the infusion of IL-6 into wounds in IL-1R KO mice did not increase fibrosis. Skin wounds in IL-1R KO animals had lower levels of collagen and improved restoration of normal skin architecture compared with skin wounds in wild-type mice. However, neither the tensile strength of incisional skin wounds nor the rate of closure of excisional wounds differed between IL-1R KO and wild-type animals. The reduced fibrotic response in wounds from IL-1R KO mice could be reproduced by the administration of an IL-1R antagonist. These findings suggest that pharmacological interference with IL-1 signaling could have therapeutic value in the prevention of hypertrophic scarring and in the treatment of fibrotic diseases. (Am J Pathol 2009, 174:2129-2136; DOI:10.2353/ajpath.2009.080765)
引用
收藏
页码:2129 / 2136
页数:8
相关论文
共 50 条
  • [31] Graves' ophthalmopathy and gene polymorphisms in interleukin-1α, interleukin-1β, interleukin-1 receptor and interleukin-1 receptor antagonist
    Khalilzadeh, Omid
    Anvari, Mehdi
    Esteghamati, Alireza
    Mahmoudi, Mahdi
    Tahvildari, Maryam
    Rashidi, Armin
    Khosravi, Farideh
    Amirzargar, Aliakbar
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 37 (06): : 614 - 619
  • [32] INTERLEUKIN-1 AND THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
    DINARELLO, CA
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1991, 372 (04): : 239 - 239
  • [33] Interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    NUTRITION, 1995, 11 (05) : 492 - 494
  • [34] THE HUMAN BURN WOUND AS A PRIMARY SOURCE OF INTERLEUKIN-1 ACTIVITY
    KUPPER, TS
    DEITCH, EA
    BAKER, CC
    WONG, W
    SURGERY, 1986, 100 (02) : 409 - 415
  • [35] Interleukin-1β and signaling of interleukin-1 in vascular wail and circulating cells modulates the extent of neointima formation in mice
    Chamberlain, J
    Evans, D
    King, A
    Dewberry, R
    Dower, S
    Crossman, D
    Francis, S
    AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (04): : 1396 - 1403
  • [36] Identification of essential regions in the cytoplasmic tail of interleukin-1 receptor accessory protein critical for interleukin-1 signaling
    Radons, J
    Gabler, S
    Wesehe, H
    Korherr, C
    Hofmeister, R
    Falk, W
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (19) : 16456 - 16463
  • [37] INTERLEUKIN-1α, INTERLEUKIN-1β AND INTERLEUKIN-1 RECEPTOR 1 GENE POLYMORPHISMS IN PSORIATIC ARTHRITIS
    Ravindran, J.
    Lagan, A.
    Owen, P.
    Korendowych, E.
    Lewis, J.
    Welsh, K.
    McHugh, N.
    RHEUMATOLOGY, 2003, 42 : 56 - 56
  • [38] Curcumin Blocks Interleukin-1 Signaling in Chondrosarcoma Cells
    Kalinski, Thomas
    Sel, Saadettin
    Huetten, Heiko
    Roepke, Martin
    Roessner, Albert
    Nass, Norbert
    PLOS ONE, 2014, 9 (06):
  • [39] Interleukin-1 Signaling Contributes to Early Islet Compensation
    Hajmrle, Catherine
    Smith, Nancy
    Spigelman, Aliya
    Dai, Xiao-Qing
    Senior, Laura
    Ferdaoussi, Mourad
    Macdonald, Patrick E.
    DIABETES, 2016, 65 : A71 - A71
  • [40] Interleukin-1β is a novel target of notch signaling in macrophages
    Morishige, K
    Tang, SMT
    Fung, E
    Aster, JC
    Aikawa, M
    CIRCULATION, 2005, 112 (17) : U56 - U56